BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24834963)

  • 1. Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.
    Kuentz M
    J Pharm Pharmacol; 2015 Feb; 67(2):143-59. PubMed ID: 24834963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing.
    Jede C; Wagner C; Kubas H; Weber C; Weitschies W
    J Pharm Pharmacol; 2018 Oct; 70(10):1315-1323. PubMed ID: 30062721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging.
    Gordon S; Naelapää K; Rantanen J; Selen A; Müllertz A; Østergaard J
    Pharm Dev Technol; 2013; 18(6):1407-16. PubMed ID: 23136844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple fiber-optic dual-beam UV/Vis system with application to dissolution testing.
    Johansson J; Cauchi M; Sundgren M
    J Pharm Biomed Anal; 2002 Jul; 29(3):469-76. PubMed ID: 12062647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.
    Brown SC; Claybourn M; Sievwright D; Fearnside V; Ashman C
    Appl Spectrosc; 2010 Apr; 64(4):442-7. PubMed ID: 20412630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of UV Imaging in Formulation Development.
    Sun Y; Østergaard J
    Pharm Res; 2017 May; 34(5):929-940. PubMed ID: 27766463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating drug delivery with salt formation: Drug disproportionation studied in situ by ATR-FTIR imaging and Raman mapping.
    Ewing AV; Wray PS; Clarke GS; Kazarian SG
    J Pharm Biomed Anal; 2015; 111():248-56. PubMed ID: 25910459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniaturized INtrinsic DISsolution Screening (MINDISS) assay for preformulation.
    Alsenz J; Haenel E; Anedda A; Du Castel P; Cirelli G
    Eur J Pharm Sci; 2016 May; 87():3-13. PubMed ID: 26360839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems.
    Phillips DJ; Pygall SR; Cooper VB; Mann JC
    J Pharm Pharmacol; 2012 Nov; 64(11):1549-59. PubMed ID: 23058042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review.
    O'Dwyer PJ; Litou C; Box KJ; Dressman JB; Kostewicz ES; Kuentz M; Reppas C
    J Pharm Pharmacol; 2019 Apr; 71(4):536-556. PubMed ID: 29956338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined approach of FTIR imaging and conventional dissolution tests applied to drug release.
    van der Weerd J; Kazarian SG
    J Control Release; 2004 Aug; 98(2):295-305. PubMed ID: 15262420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics.
    Niederquell A; Kuentz M
    Int J Pharm; 2014 Mar; 463(1):38-49. PubMed ID: 24406675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations - a PEARRL review.
    Price DJ; Ditzinger F; Koehl NJ; Jankovic S; Tsakiridou G; Nair A; Holm R; Kuentz M; Dressman JB; Saal C
    J Pharm Pharmacol; 2019 Apr; 71(4):483-509. PubMed ID: 29770440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UV imaging in pharmaceutical analysis.
    Østergaard J
    J Pharm Biomed Anal; 2018 Jan; 147():140-148. PubMed ID: 28797957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A drug dissolution monitor employing multiple fiber optic probes and a UV/visible diode array spectrophotometer.
    Chen CS; Brown CW
    Pharm Res; 1994 Jul; 11(7):979-83. PubMed ID: 7937558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing in-vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model.
    Arnold YE; Imanidis G; Kuentz MT
    J Pharm Pharmacol; 2011 Mar; 63(3):333-41. PubMed ID: 21749380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the applications of vibrational spectroscopic imaging and mapping to pharmaceutical formulations.
    Ewing AV; Kazarian SG
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 May; 197():10-29. PubMed ID: 29290567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.